FHTX
Foghorn Therapeutics Inc.Company with tickers: FHTX
CIK
1822462
CUSIP
344174107
Shares Outstanding
58,713,922
13F Activity (30d)
94 filings
92 filers
Price
$4.25
Market Cap
$247.77M
P/E Ratio
-3.60
EPS (Diluted)
$-1.18
52W High
$6.95
52W Low
$3.27
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $3,267,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $24,840,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $18,259,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-21,573,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-19,875,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.29 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.29 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |